Abstract
We recently isolated and characterized a human milk peptide, lactaptin, which induced apoptosis of cultured human MCF-7 cells. Lactaptin was identified as a proteolytic fragment of human kappa-casein. Here, we generated two recombinant analogs of the peptide, RL1 and RL2, containing truncated and complete amino acid sequences of lactaptin, respectively. Analogs were produced in E.coli, purified and assayed for biological activity on cultured human MCF-7 cells. RL1 was shown to induce only a small decrease in cell viability, whereas RL2 lowered the viability of MCF-7 cells by 60%. This reduction in MCF-7 cell viability was associated with apoptosis, which was indicated by phosphatidilserine externalization and caspase-7 activation. The viability of A549 and Hep-2 cells was also reduced by RL2, albeit to a lesser degree than seen with MCF-7 cells; this reduced viability was not accompanied by apoptosis. Non-malignant human mesenchymal stem cells (MSC) were completely resistant to RL2 action.
Similar content being viewed by others
Abbreviations
- DFF45:
-
DNA fragmentation factor 45 kDa
- FITC:
-
Fluorescein isothiocyanate
- MSC:
-
Mesenchymal stem cells
- MTT:
-
3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
- PI:
-
Propidium iodide
- PS:
-
Phosphatidylserine
- TNF-α:
-
Tumor necrosis factor alpha
References
Akiyoshi T, Matzno S, Sakai M, Okamura N, Matsuyama K (2009) Cancer Chemother Pharmacol 65:143–150
Cohen GM (1997) Biochem J 326:1–16
Creamer LK, Plowman JE, Liddell MJ, Smith MH, Hill J (1998) J Dairy Sci 81:3004–3012
Edlund A, Johansson T, Leidvik B, Hansson L (1996) Gene 174:65–69
Elmore S (2007) Toxicol Pathol 35:495–516
Florisa R, Recio I, Berkhout B, Visser S (2003) Curr Pharm Des 9:1257–1275
Hallgren O, Aits S, Brest P, Gustafsson L, Mossberg AK, Wullt B, Svanborg C (2008) Adv Exp Med Biol 606:217–240
Janicke RU, Ng P, Sprengart ML, Porter AG (1998) J Biol Chem 273:15540–15545
Janicke RU, Sprengart ML, Wati MR, Porter AG (1998) J Biol Chem 273:9357–9360
Kanyshkova TG, Babina SE, Semenov DV, Isaeva N, Vlassov AV, Neustroev KN, Kul’minskaya AA, Buneva VN, Nevinsky GA (2003) Eur J Biochem 270:3353–3361
Kottke TJ, Blajeski AL, Meng XW, Svingen PA, Ruchaud S, Mesner PW Jr, Boerner SA, Samejima K, Henriquez NV, Chilcote TJ, Lord J, Salmon M, Earnshaw WC, Kaufmann SH (2002) J Biol Chem 277:804–815
Liepke C, Zucht HD, Forssmann WG, Ständker L (2001) J Chromatogr B Biomed Sci Appl 752:369–377
Mc Gee MM, Hyland E, Campiani G, Ramunno A, Nacci V, Zisterer DM (2002) FEBS Lett 515:66–70
Meisel H, FitzGerald RJ (2003) Curr Pharm Des 9:1289–1295
Nekipelaya VV, Semenov DV, Potapenko MO, Kuligina EV, Kit YY, Romanova IV, Richter VA (2008) Dokl Biochem Biophys 419:58–61
Onishi J, Roy MK, Juneja LR, Watanabe Y, Tamai Y (2008) J Pept Sci 14:1032–1038
Samali A, Zhivotovsky B, Jones D, Nagata S, Orrenius S (1999) Cell Death Differ 6:495–496
Semenov DV, Aronov PA, Kuligina EV, Potapenko MO, Richter VA (2003) Biochemistry (Mosc) 68:1335–1341
Shah NP (2000) Br J Nutr 84:3–10
Swaisgood H (1975) J Dairy Sci 58:583–592
Wolf BB, Schuler M, Echeverri F, Green DR (1999) J Biol Chem 274:30651–30656
Zhivotovsky B, Orrenius S (2006) Carcinogenesis 27:1939–1945
Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, Alfonso ZC, Fraser JK, Benhaim P, Hedrick MH (2002) Mol Biol Cell 13:4279–44295
Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, Benhaim P, Lorenz HP, Hedrick MH (2001) Tissue Eng 7:211–228
Acknowledgments
This work was supported by a grant from the Russian Federal Agency for Science and Innovations, State contract # 02.512.11.2257, #02.522.12.2005 and by an Integration Grant from the Presidium of SB RAS № 18.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Semenov, D.V., Fomin, A.S., Kuligina, E.V. et al. Recombinant Analogs of a Novel Milk Pro-Apoptotic Peptide, Lactaptin, and Their Effect on Cultured Human Cells. Protein J 29, 174–180 (2010). https://doi.org/10.1007/s10930-010-9237-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10930-010-9237-5